Time required to achieve optimum viral load suppression with Ravidasvir/sofosbuvir in chronic hepatitis C patients with or without compensated cirrhosis

Abstract A study indicated that ravidasvir (RDV) has excellent safety and tolerability when used with sofosbuvir (SOF) to treat chronic HCV infection. The aim of this study was to determine the time taken by RDV/SOF to achieve optimum viral load suppression in chronic hepatitis C patients with or wi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nor Asiah Muhamad, Izzah Athirah Rosli, Nur Hasnah Maamor, Rozainanee Mohd Zain, Fatin Norhasny Leman, Huan-Keat Chan, Muhammad Radzi Abu Hassan, Shahnaz Murad
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-04-01
Col·lecció:	Scientific Reports
Matèries:	Ravidasvir Sofosbuvir Hepatitis Time-to-event Virologic response STORM-C-1
Accés en línia:	https://doi.org/10.1038/s41598-025-99665-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!